Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer

被引:0
|
作者
Cengiz Beyan
Esin Beyan
机构
[1] Ufuk University Faculty of Medicine,Department of Internal Medicine
[2] University of Health Sciences,undefined
[3] Kecioren Training and Research Hospital,undefined
关键词
Drug therapy; Mean platelet volume; Predictive value of tests; Prognosis; Prostatic neoplasms;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2175 / 2176
页数:1
相关论文
共 50 条
  • [21] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [22] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    de Bono, J.
    Mateo, J.
    Fizazi, K.
    Saad, F.
    Shore, N.
    Sandhu, S.
    Chi, K. N.
    Sartor, O.
    Agarwal, N.
    Olmos, D.
    Thiery-Vuillemin, A.
    Twardowski, P.
    Mehra, N.
    Goessl, C.
    Kang, J.
    Burgents, J.
    Wu, W.
    Kohlmann, A.
    Adelman, C. A.
    Hussain, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2091 - 2102
  • [23] Advances in metastatic castration-resistant prostate cancer
    Kentepozidis, Nikolaos
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S108 - S108
  • [24] Rucaparib in castration-resistant, metastatic prostate cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2024, 55 (02) : 96 - 98
  • [25] Management of Metastatic Castration-Resistant Prostate Cancer
    Srinivas, Sandy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 614 - 616
  • [26] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    Heidegger, Isabel
    Pircher, Andreas
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (09): : 890 - 891
  • [27] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [28] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
  • [29] Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistant prostate cancer
    Vidal, M.
    Cardenas-Perilla, R.
    Delgado, A.
    Moron, S.
    Blair, J. L. Londono
    Vega, I.
    Ochoa, J. J. Correa
    Rojas, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 310 - 317
  • [30] Quality of life outcomes for patients with metastatic castration-resistant prostate cancer and pretreatment prognostic score
    Oyenuga, Mosunmoluwa
    Halabi, Susan
    Oyenuga, Abayomi
    McSweeney, Sean
    Morgans, Alicia K.
    Ryan, Charles J.
    Prizment, Anna
    PROSTATE, 2023, 83 (07): : 688 - 694